“Low Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in Brain Tumor Patients ” (2012) Journal of Cancer Research Updates, 1(1), pp.  44–48. doi:10.6000/1929-2279.2012.01.01.08.